Synagis

Dogenous i.e., simultaneously determined ; . The empirical tests turned out to be negative for total and short-term unemployment but positive for long-term unemployment. The correction of this "simultaneity bias" with the help of an instrumental variables approach and TSLS estimation techniques revealed a slope parameter of the total tax rate that was much higher than the one originally received from OLS estimation. The reason seems to be that the relationship between taxation and long-term unemployment is a mutually reinforcing one: a rising total tax rate leads to higher long-term unemployment rate and government expenditures ; which in turn leads to a higher tax rate. Additional calculations revealed that a reduction in the total tax rate of about one standard deviation 11.5 percentage points ; --a magnitude that is smaller than the difference between the total tax rate in Europe and non-Europe7--leads to a reduction of long-term unemployment in the order of 3.2 percentage points. This magnitude is within the range of the difference of the long-term unemployment rate between Europe and non-Europe. 160; abbott agrees and acknowledges that neither abbott nor its affiliates has been granted any rights by medimmune either under this agreement or otherwise ; to research, manufacture, develop, market, promote, sell or distribute numax outside of the territory or synagis outside of the territory, except, in the case of synagis, pursuant to the terms of that 6 certain co-promotion agreement, dated as of november 26, 1997, by and between medimmune and abbott laboratories through its ross products division ; , as amended. Effective November 1, 2004, the South Carolina Department of Health and Human Services DHHS ; will implement new changes for the administration of Synagis. Payment for Synagis administration will be limited to six doses per season given on or after October 1st and no later than March 31st. Prior approval will not be required for up to six doses as long as they are given at least 30 days apart and meet the guidelines of the American Academy of Pediatrics AAP ; for Synagis administration. Any dose over the limit of six or administered after the RSV season October March ; will require prior approval. Discretion should be used in the administration of Synagis to those infants born between 32 and 35 weeks gestation that do not have chronic lung disease. DHHS will not reimburse providers for Synagis administration to children in this age group that do not have two or more risk factors listed in the AAP guidelines. Doses given to children greater than two years of age will not be approved for payment under any circumstances. Providers must dose appropriately for each child according to their weight. Payment for doses in infants six months of age to two years of age must be in accordance with AAP guidelines. Providers using more than 50 mg of Synagis must bill multiple units of the 50 mg vial, not to exceed four units. This will result in a reimbursement of 2.00 for 50 mg, , 304.00 for 100 mg, , 956.00 for 150 mg, and , 608.00 for 200 mg.
Challier B, Perarnau JM, Viel JF. Garlic, onion and cereal fibre as protective factors for breast cancer: a French case-control study. Eur J Epidemiol 1998; 14: 737-47. Cell previously labeled with calcein. After 1 h, no calcein fluorescence could be observed on either the unlabeled NK cells Fig. 3D ; or the unlabeled target cells Fig. 3E ; , suggesting that there was no mixing of cytoplasm. Pneumatic cylinder UC2 32 x20 farolfi for first pincer First pincer Pneumatic cylinder UC2 40x35 farolfi for pre-heating Vacuum pump completed with motor Oil seal for above pump Vacuum blades for above pump Maine drive v-belt S 301 4 57 Filter housing complete for vacuum pump Filter cartridges for above Small screws, washers, nuts, .etc of the whole machine Water cooling unit assembly Water pump completed Mechanical seal assembly for above pump Refrigeration compressor for above cooling unit Oil seal + "O" ring for hydraulic cylinder f.n, N.6 ; The pincer Fig P, N.1 ; Gear box for main drive machine Pulley for above gear box Caps springs in forming station 40-10, 2-0, 9 Springs in forming sealing station Springs for aluf oil brake Springs for idle pincer Compensating roller return springs Bearing No. NUTR 4090 Bearing No. NUTR 2562 Exit pincer springs drawing Arial ; Stabilizer springs De-vacuum valve springs Kit gaskets for 22 sealing oil cylinder Kit gaskets for 32 pincers cylinder and synvisc.

WC186 WC187 ZenithThoracic Endovascular Graft Zenith Thoracic Endovascular Graft Thoracic Proximal Graft Thoracic Distal Graft 22mm to 42mm diameter; 115mm to , 055.00 216mm length 26mm to 42mm diameter; 127mm to , 055.00 207mm length. This field identifies the date on which the order was administered. The system prefills this field with today's date for active patients or with the patient's discharge date for discharged patients. If a patient's status changes from outpatient to inpatient, you can enter a date as early as the outpatient admission date for the patient in this field. If you enter a date that precedes the patient's admission date or is after the default date, the system displays an Invalid date! error message and prompts you to enter a valid date. The system accepts a date prior to the date of inpatient Admission if the patient was an Outpatient or ER Patient under the same account number prior to their Inpatient Admission and tace.
86. Barton, M. E.; White, H. S. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on kindling acquisition and expression. Epilepsy Res. 2004, 59, 1-12. Bannon, A. W.; Decker, M. W.; Holladay, M. W.; Curzon, P.; Donnelly-Roberts, D.; Puttfarcken, P. S.; Bitner, R. S.; Diaz, A.; Dickenson, A. H.; Porsolt, R. D.; Williams, M.; Arneric, S. P. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science 1998, 279, 77-81. Badio, B.; Daly, J. W. Epibatidine, a potent analgetic and nicotinic agonist. Mol. Pharmacol. 1994, 45, 563-569. Marubio, L. M.; del Mar Arroyo-Jimenez, M.; Cordero-Erausquin, M.; Lena, C.; Le Novere, N.; de Kerchove d'Exaerde, A.; Huchet, M.; Damaj, M. I.; Changeux, J. P. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 1999, 398, 805-810. McIntosh, J. M.; Santos, A. D.; Olivera, B. M. Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. Annu. Rev. Biochem. 1999, 68, 59-88. Dutton, J. L.; Craik, D. J. alpha-Conotoxins: nicotinic acetylcholine receptor antagonists as pharmacological tools and potential drug leads. Curr. Med. Chem. 2001, 8, 327-344. Sandall, D. W.; Satkunanathan, N.; Keays, D. A.; Polidano, M. A.; Liping, X.; Pham, V.; Down, J. G.; Khalil, Z.; Livett, B. G.; Gayler, K. R. A novel alpha-conotoxin identified by gene sequencing is active in suppressing the vascular response to selective stimulation of sensory nerves in vivo. Biochemistry 2003, 42, 6904-6911. Lang, P.; Burgstahler, R.; Sippel, W.; Irnich, D.; Schlotter-Weigel, B.; Grafe, P. Characterization of neuronal nicotinic acetylcholine receptors in the membrane of unmyelinated human C-fiber axons by in vitro studies. J. Neurophysiol. 2003, 90, 3295-3303. Satkunanathan, N.; Livett, B.; Gayler, K.; Sandall, D.; Down, J.; Khalil, Z. Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones. Brain Res. 2005. 95. Wood, J.; Boorman, J.; Okuse, K.; Baker, M. Voltage-gated sodium channels and pain pathways. J. Neurobiol. 2004, 61, 55-71. Daly, N. L.; Ekberg, J. A.; Thomas, L.; Adams, D. J.; Lewis, R. J.; Craik, D. J. Structures of muO-conotoxins from Conus marmoreus. I nhibitors of tetrodotoxin TTX ; -sensitive and TTXresistant sodium channels in mammalian sensory neurons. J. Biol. Chem. 2004, 279, 25774-25782. West, P. J.; Bulaj, G.; Garrett, J. E.; Olivera, B. M.; Yoshikami, D. Mu-conotoxin SmIIIA, a potent inhibitor of tetrodotoxin-resistant sodium channels in amphibian sympathetic and sensory neurons. Biochemistry 2002, 41, 15388-15393. Bulaj, G.; West, P. J.; Garrett, J. E.; Marsh, M.; Zhang, M. M.; Norton, R. S.; Smith, B. J.; Yoshikami, D.; Olivera, B. M. Novel conotoxins from Conus striatus and Conus kinoshitai selectively block TTX-resistant sodium channels. Biochemistry 2005, 44, 7259-7265. Buchan, A. M.; Gertler, S. Z.; Li, H.; Xue, D.; Huang, Z. G.; Chaundy, K. E.; Barnes, K.; Lesiuk, H. J. A selective N-type Ca 2 + ; -channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia. J. Cereb. Blood Flow Metab. 1994, 14, 903-910. Valentino, K.; Newcomb, R.; Gadbois, T.; Singh, T.; Bowersox, S.; Bitner, S.; Justice, A.; Yamashiro, D.; Hoffman, B. B.; Ciaranello, R.; et al. A selective N-type calcium channel. Respigam must be administered intravenously while synagis can be injected and tacrine. As mentioned in the foreword sub par. 1.2 ; , those taxpayers who were engaged in more than one business activity for which, by law or by choice, they have kept separate accounting books pursuant to Art. 36, must fill in, in addition to the front page, as many forms as the accounting systems they follow. In particular, it is specified that: the data to be reported in sections 1 and 2 of part VA and in section 1 of part VL, as well as parts VE, VF, VG and VJ concern each single separate accounting system and must therefore be filled in each form; on the other hand, the data to be reported in sections 3 and 4 of part VA and in the section 2 of part VL and parts VC, VD, VH, VK, VT, VX and VO concern the total of the businesses performed and therefore must be summarized in just one form, namely in the first form completed. NOTICE: it is specified that if several activities are performed using separate accounts, with one of these activities being exempt from the obligation of filing the VAT return, for this activity there is no obligation to include the relevant form in the return e.g. farmers under art. 34, par. 6, 1st and 2nd period; proprietors of entertainment businesses under art. 74, par. 6 ; . Instead, taxpayers performing both taxable and exempt activities with separate accounts shall include the form concerning the exempt activity performed in their return, too. If the taxpayer is exempt from obligations pursuant to art. 36 bis, the form concerning the exempt activity shall include the accounting data concerning purchases and the amount of the exempt operations under nos. 11, 18 and 19 of art. 10, for which the obligation of invoicing and registration remains. Taxpayers who are legally obliged art. 36, par. 2 and 4 ; to keep separate accounts for the activities they perform shall refer to their relevant business turnovers to establish whether their VAT returns shall be filed monthly or quarterly. On the other hand, those taxpayers who voluntarily adopt separate accounts shall refer for this purpose to the total business volume of their activities. Consequently, if separate accounts are kept by law, the taxpayer may be required to make monthly payments for one or more activities and quarterly payments for the other activities. On the other hand, those taxpayers who voluntarily adopt separate accounts shall refer to the total business turnover of their activities concerning all activities performed ; to calculate the frequency of their payments. In relation to this last case, it is specified that if the total business turnover is not higher than the limits established by regulations in force, the quarterly payment system can be adopted only for one or more accounts kept. Internal changeovers among separate activities do not contribute to form the business turnover. When i wrote my wishes when i had him we refused all vaxes and mentioned that if he was still in the hospital when synagis was offered we would like to talk to his neonatologist about it so we could see if it was right for him and tamiflu.

First 7 countries ; + second 12 c ; waves; main concerns at industrial level: a lack of attractivity of the sector; the inaccuracy of the vocational training systems; the high competitive pressure from low wages countries; the necessary modernisation of production methods. Source: Accra Study Team 1998. Note: N 558. a This question was asked only of biological mothers N 553 ; b For diphtheria, pertussis, and tetanus DPT ; immunization, the sample includes only children older than 3 months, and for measles, the sample includes children older than 9 months ages at which these two immunizations are expected to be completed and tao.
Int.Cl.6 A61K 45 00. Pharmaceutical products. RUSSINSKY LIMITED Int.Cl.6 B29C 70 48; B29D 31 00. COMPOSITE ARTICLE AND METHOD FOR MANUFACTURING THE SAME. 3-D COMPOSITES LIMITED.

TABLE 7 of the FY 2001 Final Rule for SNFs MSA Published Wage Index 0200 Albuquerque, NM 0.9750 3810 Killeen-Temple, TX 0.7292.
Nearly 80% of C. difficile spores had germinated, with the majority of organisms detected in the small intestine 31 ; . They suggested that germination occurred in the small intestine of hamsters upon exposure to bile salts. It is notable that bile salts are commonly detected in esophageal aspirates of patients with gastroesophogeal reflux disease GERD ; 19 ; , a common malady with 4-7% of the adults experiencing daily symptoms 24 ; . If bile salts within gastric contents stimulate germination, the resultant vegetative form of C. difficile will be more likely to survive and cause infection among individuals receiving PPI therapy for GERD. In this study, while we did not specifically assay for the presence of bile acid in gastric contents, two grossly bilious samples were among the eight samples collected from patients with nasogastric tubes taking proton pump inhibitors. Interestingly, bile salts stimulate C. difficile germination in vitro, an interesting characteristic that we are currently investigating 30 ; . In summary, we found that the vegetative form of C. difficile was shed in feces in significant quantities prior to initiation of treatment for CDAD and remained viable in room air on moist surfaces and in gastric contents with elevated pH. Future work is and targretin.

Raid on June 28, 1969. Although not the nation's first gay civil rights demonstration, Stonewall is now regarded as the birth of the modern gay civil rights movement. straight adj. ; : Heterosexual; describes a person whose sexual and affectional attraction is to someone of the opposite sex. transgender adj ; : An umbrella term that refers to people whose biological and gender identity or expression may not be the same. This can include preoperative, postoperative or nonoperative transsexuals, female and male cross-dressers, drag queens or kings, female or male impersonators, and intersex individuals. If an individual prefers to be called transsexual, drag queen or king, intersex, etc., use that term. When writing about a transgender person, use the name and personal pronouns that are consistent with the way the individual lives publicly. transition: The process by which one alters one's sex. This may include surgery, hormone therapy and changes of legal identity. transsexual n. ; : An individual who identifies himself or herself as a member of the opposite sex and who acquires the physical characteristics of the opposite sex. Individual can be of any sexual orientation. To determine accurate use of names or personal pronouns, use.
1. VOLKER, J.F.; HODGE, H.C.; WILSON, H.J.; and VAN VooRms, S.H.: The Absorption of Fluorides by Enamel, Dentin, Bone and and tarka. This is a highly nonlinear problem whose solvability is not trivial at all. In the appendix we prove, for small , existence of a unique solution close to S and satisfying the qualitative ~ is completely determined by the poassumptions mentioned above. The fact that ~, S ; sitions x1 , the plateau boundaries motivates the notation x; x1 , these coincide with the points where a stationary cell density takes the value 1 2, then all the i vanish and ~, S ; is an exact steady state, since it ~ also satisfies the Neumann boundary conditions x 0, x 0, L, by its construction ~ ~ In general, however, we obtain the residual and by the boundary conditions for S. ~ R ~i-1 2 , xi + 1. Medimmune estimates that synagis was used in its first season in the by 15 to 20% of the children who could potentially benefit from its use and taxol and synagis. Which can be disposed of in landfills. However, to avoid dioxin production, no chlorinated plastic bags and preferably no other chlorinated compounds ; should be introduced into the incinerator, and should therefore not be used for packaging waste before its incineration. Design and size of a pyrolytic incinerator Optimal combustion conditions are essential if there is to be almost complete destruction of wastes without the generation of significant amounts of harmful solid, liquid, or gaseous outputs e.g. dioxins, furans ; . The burning temperature, waste residence time inside the furnace, gas turbulence, and size of airflow inputs are therefore critical, and the incinerator should fulfil the following criteria. Novartis is a world leader in pharmaceuticals that aims to improve patients' lives through scientific innovation. Novartis is currently conducting research to advance overactive bladder management. Through this endeavor, Novartis strives to meet its ongoing goal of exerting a positive impact on patients' lives and taxotere. By activity, but by percentage the distributions agree with those by the Sepharose method. The apparent proportion of BB activity is greater with the Sephadex column for sera with above-normal CK activity, indicating carryover of MB into the BB fraction. The Sephadex column, however, is able to detect above-normal MB, showing that the method is nonetheless diagnostically valid. To investigate the linear range of the Sepharose column, we used different sample sizes and plotted sample size vs activity in the fractions Figure 6 ; . The results indicate that the column performs as expected for 0.1- to 0.5-mL samples containing 1200 UIL. Electrophoresis of the concentrated column fractions, however, indicates slight MB contamination in the MM fraction with the 0.5-mL sample. Within-day precision of the column separation was determined on three samples normal, above-normal, and an enriched human serum pool ; , each assayed on 10 columns. Day-to-day precision was determined over a period of 10 days. The author is associate director for research, family medicine residency, swedish medical center, and associate clinical professor of pediatrics and health services, university of washington, seattle. Synagis palivizumab ; has recentlybeen approvedby the Food and Drug Administration FDA ; for use in the prevention of seriouslower respiratorytract diseases caused respiratory by syncytial virus RSV ; in pediatric patientsat high risk for RSV disease. Because the high of cost of this medication, prescribersare reluctant to follow the normal billing procedureof purchasingthe drug and submitting to the Statefor reimbursement with their office visit charges. Medicaid pharmacyregulationsallow for injectablesto be dispensed a pharmacy by provider for administrationby the prescriberwhen authorized the Departmentto be covered by under the PharmacyProgram. Basedon this regulation and to ensureproper access and appropriateuse of Synagis, the Departmenthas developed specialbilling procedureand a authorizationform to be used when administeringthis producton an outpatientbasisto fee-forservice Medicaid recipients. If the patient is in an MCO, you shouldobtain billing instructions from an MCO representative Instrnctions for the Ph ; : sician The authorizationform included with this transmittalshouldbe filled out, signedby the prescriber and faxed to the Medical Care Financeand ComplianceAdministration 410-333-7049 ; before Synagisis anministered. The prescriber shouldwrite a prescription for the amount required and forward it to the pharmacyeither by fax or hard copy. The amount shouldcover a one month supply and may include up to two refills. Because product must be refrigerated this.
In February 2004, Plaintiffs submitted their affirmative expert reports, which relied on testing performed on Impax's ANDA samples the only samples Impax had produced at that time ; . Plaintiffs allege that although Impax started preparations for commercial-scale production before the scheduled due date for affirmative expert reports, Impax did not inform them of the availability of these commercial-scale pellets or their forthcoming small-scale samples. In June 2004, Plaintiffs filed a Motion to Determine Whether the Impax Samples Are Representative, which Impax timely opposed. Plaintiffs requested a hearing on the.

I have MS so I understand the daily struggle and the desperate hope for a cure, but we must remember that those with other problems also need resources and the finances are limited. We must try to get the best value for as many people as possible. Sue Ferreira, Cambridge g.ferreira virgin Dear New Pathways, It is clear from your publication that there is a great wealth of alternative therapies that MS sufferers turn to. Whilst many of the alternative approaches would be rejected out of hand by most doctors, particularly out of ignorance, there is a growing acceptance amongst the medical profession for what we would perhaps like to call more complementary therapies such as Homeopathy and Acupuncture. Looking through your magazine there is no mention at all about Homeopathic approaches to the treatment of MS. This I find surprising and perhaps a little disappointing as many experienced Medical Homeopaths have probably had a good deal of experience and success in treating MS. Dr Andrew Hillam, MBBS MRCGP LFHOM Stokewood Surgery, Eastleigh, Hants Ed replies: Dear Dr Hillam Give us a chance! This is only our third issue. We will definitely cover Homeopathy in a forthcoming issue. How about writing something for us yourself? and synvisc. Absence of antibiotic selection pressure. Proc. Natl. Acad. Sci. U S A 102: 541-546. 16.
Fig. 2. An algorithm for evaluating drug-drug interactions.

SYNAGIS Medical Exception Worksheet Prescription Order Form. Please FAX this completed form to Unison Health Plan Pharmacy Department at: Fax: 412 ; 457-1328 or 866 ; 639-7785.

Home marketing services news reports company profiles indepth drug discovery careers conferences videos search contact buy: biopharma: biopharmaceutical products in the market 3rd edition table of contents table of content - alphabetical order sample monographs full text ; : rsv mab, rdna synagis from medimmune ; epo rdna amgen fda approvals buy: biopharma: biopharmaceutical products in the market 3rd edition biopharma: biopharmaceutical products in the market see 4th edition - click here biopharma is the only reference book concerning biopharmaceutical products. Paulides M.M., Bakker J.F. and Van Rhoon G.C. Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands email: M.Paulides ErasmusMC.nl ; Introduction Hyperthermia HT ; has a high potential to improve treatment results in Head and Neck H&N ; patients. However, an appropriate applicator that can heat both superficial and deep located target regions is not available. In previous studies 1 2 we investigated the possibilities of focussed RF HT for the neck region. We found that a setup of six to eight antennas, operating at 433MHz, can be used to obtain the desired power absorption PA ; pattern in the neck. In the present study we extend the previous work and converge towards one array setup, with multiple antenna rings, that meets the clinical demands. Hereto we investigated the ability to deposit RF-energy centrally in the neck as a function of patient positioning, antenna ring radius R ; , number of antenna rings, number of antennas per ring and distance between the outer antenna rings D ; . Materials and methods PA distributions in two realistic small and large patient ; anatomy models were calculated. These head models were irradiated by several configurations utilising one, two or three circular arrays consisting of four to eight antennas, i.e. 1x8, 2x4, 2x6, and 3x4 arrangements. The relative PA distributions corresponding to different set-ups were visualised and analysed using the ratio of the average PA aPA ; in the central target region and neck region. Results Proper patient positioning was found to be highly important for a high aPA ~30% variation ; . For an increasing ring radius 12.5-25cm ; we found a 15% decrease in aPA. Increase of the number of antenna rings from one to two or three led to around 20% more power focussing. aPA ratios remained approximately stable for D 6cm but decreased for D 6cm due to a decreased central power intensity. aPA ratios were comparable for a 2x6 and 3x4 arrangement and only a moderate increase was observed for a 2x8 arrangement. Conclusions A single optimum array setup for all patients remains difficult to define since this is highly dependent on anatomy and target locations. Based on the aPA results, practical limitations and potential for axial steering, we selected a 2x6 setup with R 20cm and D 6cm for the clinical applicator design. Acknowledgement This work is supported by the Dutch Cancer Society, grant no. DDHK 2003-2855. All evaluated patients were less than or equal to 35 weeks gestational age and received at least one dose of synagis between september 1998 and may 199 the data showed that the rsv hospitalization rate in all patients receiving synagis was 3 percent.

CLINICAL STUDIES: The safety and efficacy of Synagis were assessed in two randomized, doubleblind, placebo-controlled trials of prophylaxis against RSV infection in pediatric patients at high risk of 1 was conducted during a single RSV season and studied a total an RSV-related hospitalization. Trial. MAbs are on a wave of growth with more drugs and revenues to come. It is forecasted that, worldwide, the therapeutic MAb sector will generate sales in excess of billion in 2005, rising from billion in 2002. Compound annual growth is 25% over the period. It should be pointed out that most of the revenue increase will come from the five approved MAbs [Remicade Centocor, Malvern, PA ; , ReoPro Cento-cor ; , Rituxan Genentech, South San Francisco, CA ; , and Table 2: Sales and growth of antibodies by therapy area, 2002 Synagis MedTherapy area Sales 2001 Sales 2002 Growth % ; Immune, Gaith mil$ ; mil$ ; ersburg, MD ; and Avastin GenenOncology 1, 665 2, tech ; . AIID 922 1, 668. Difference of the means was evaluated by Dunnet's ttest. RESULTS The results of the preliminary phytochemical screening of the ethanolic extract and its fractions are given in Table 1. In acute toxicity study, it was found that the extract induced sedation, diuresis, purgation, and temporary postural defect at all tested doses. However, there was no mortality at any of the tested doses till the end of 14 days of observation. The ethanolic extract was found to produce significant increase in excretion of sodium, potassium and chloride ions at the higher dose tested 400 mg kg p.o. ; . The order of activity of increase of urinary output was diethyl ether fraction n-butanol fraction ethyl acetate fraction petroleum ether fraction. The order of activity of increase of urinary electrolyte excretion was found to be n-butanol fraction diethyl ether fraction ethyl acetate fraction petroleum ether fraction. In the evaluation of laxative activity, the ethanolic extract was found to produce significant dose dependant activity at both the tested level of doses 200 and 400 mg kg, p.o. ; . The effect was superior to that of the standard tested at 400mg kg, p.o. dose level. The order of activity for the ethanolic extract fractions was diethyl ether fraction ethyl acetate fraction n-butanol fraction petroleum ether fraction. DISCUSSION The present study revealed that, ethanolic extract of Cleome rutidosperma significantly increased the urinary output as well as urinary electrolyte concentration at a higher dose tested 400mg kg, p.o. ; . The fractionation of ethanolic extract potentiated the activity. The diethyl ether fraction was found to be the most potent in increasing the urinary output; the effect was comparable to that of the standard drug, whereas, the petroleum ether fraction was found to be least potent. Determination of urinary electrolyte concentration revealed that, n-butanol fraction was most effective in increasing urinary electrolyte concentration for all the three ions tested Na + , K Cl- ; . All fractions except petroleum ether fraction caused similar type of increase of urinary electrolyte concentration, but to a lesser extent. Petroleum ether fraction did not increase urinary electrolyte concentration.

Nanotubes on Ambient Substrate by Remote Spark Discharge under Atmospheric Pressure Niu W.W., Yang Y., * Whidden T.K.